idarubicin has been researched along with oxamflatin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cerruti, L; Darcy, PK; Jackson, JT; Jane, SM; Johnstone, RW; Smyth, MJ; Tainton, KM; Tanner, JE | 1 |
1 other study(ies) available for idarubicin and oxamflatin
Article | Year |
---|---|
Mutational analysis of P-glycoprotein: suppression of caspase activation in the absence of ATP-dependent drug efflux.
Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caspases; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Nucleus; Cell Survival; Cytochromes c; DNA Mutational Analysis; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Enzyme Activation; Green Fluorescent Proteins; Humans; Hydrolysis; Hydroxamic Acids; Idarubicin; Lymphoma; Mitosis; Mutation; Retroviridae; Structure-Activity Relationship; Time Factors; Vincristine | 2004 |